August 14th, 2013
Advanced Lipoprotein Analysis: Time for Widespread Implementation?
Behnood Bikdeli, M.D.
Will advanced lipoprotein analysis add real value to patients’ lives?
NEJM — Recent Cardiology Articles- Double Take: HFpEF Explained — Living with HFpEF May 7, 2026This patient-focused Double Take video describes heart failure with preserved ejection fraction and how it is managed.
- Price of Protection — Microaxial Flow Pump in High-Risk PCI May 7, 2026In the catheterization laboratory, the most consequential decisions are frequently not about whether to treat, but rather about how far to extend treatment. Nowhere is that tension more apparent than in high-risk percutaneous coronary intervention (PCI). In these cases, the margin between a good outcome and a catastrophic one is...
- Left Ventricular Unloading in High-Risk Percutaneous Coronary Intervention May 7, 2026Among patients undergoing complex PCI, elective unloading with a microaxial flow pump did not reduce the risk of major adverse clinical outcomes as compared with standard care.
- Shock Not Advised April 30, 2026A physician offers to help in a medical emergency on a transatlantic flight. Though she faces limits of bureaucracy, equipment, and ultimately biology, she discovers her physicianhood is inescapable.
- Double Take: HFpEF Explained — Managing HFpEF in Primary Care April 30, 2026This Double Take video reviews pharmacologic and nonpharmacologic interventions for heart failure with preserved ejection fraction.
- Double Take: HFpEF Explained — Living with HFpEF May 7, 2026